Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMG-007 Long-term Extension Study in Moderate-To-Severe Atopic Dermatitis
NCT07734415Phase 2Enrolling by invitation
- Start
- Jun 2026
- Primary completion
- Mar 2028
- Countries
- 2
01
Overview
A Phase 2 trial of IMG-007 in atopic dermatitis (AD). Started Jun 2026; status: enrolling by invitation.
02
Drugs
IMG-007
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07734415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07734415.